Determination of red blood cell distribution width in patients with primary cutaneous vasculitis compared to systemic vasculitis

Authors

  • Farhana Wahab Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh
  • Mohammad Jamal Uddin Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh
  • ATM Asaduzzaman Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh
  • Mohammod Abu Hena Chowdhury Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh
  • Hasan Mahmud Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh
  • Rehnuma Nasim Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh

DOI:

https://doi.org/10.66344/jpad.v31i3.1619

Keywords:

Red blood cell distribution width, Vaculitis, bsmmu

Abstract

Background Red blood cell distribution width (RDW) has been considered as an inflammatory marker in various disorders.  Evaluation of RDW value can also be used as a novel and additional marker for differentiating systemic vasculitis from primary cutaneous vasculitis.

 

Objective To compare RDW value between patients with cutaneous vasculitis with systemic vasculitis, thereafter  to find out it's role as an effective indicator to distinguish both forms of vasculitis.

 

Methods This cross sectional observational study was conducted between from July 2016 to December 2017. Total of 48 patients were divided into primary cutaneous vasculitis and systemic vasculitis. Blood was collected in EDTA tube to measure RDW value. Patient’s disease activity also scored and plotted according to Birmingham vasculitis activity score. Statistical analysis was performed by using SPSS.

 

Results Significantly high mean RDW were found in patients with systemic vasculitis compared to primary cutaneous vasculitis (15.09±0.92 vs. 13.48±1.1, p = 0.000). BVAS was significantly greater (13.93±5.10 vs. 4.87±2.69, p = < 0.001) in systemic vasculitis as well as in patients with high RDW group (11.73±5.71 vs. 5.37±3.96, p = < 0.001).  Optimal RDW cut off point for differentiating systemic vasculitis from cutaneous vasculitis was 14.2 with 81.3% sensitivity and 81.2% specificity.

 

Conclusion Present study revealed importance of RDW monitoring along with disease activity in patients with any form of vasculitis. Systemic vasculitis had higher level of RDW. So RDW can be considered as a marker to discriminate systemic vasculitis from primary cutaneous vasculitis.

 

Author Biographies

  • Farhana Wahab, Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh
    Medical Officer,Kuwait Bangladesh Friendship Government Hospital, Dhaka
  • Mohammad Jamal Uddin, Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh

    Associate Professor,Dermatology Department ,

    Bangabandhu Sheikh Mujib Medical University

    Shahbag, Dhaka, Bangladesh

  • ATM Asaduzzaman, Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh

    Associate Professor,Dermatology Department ,

    Bangabandhu Sheikh Mujib Medical University

    Shahbag, Dhaka, Bangladesh

  • Mohammod Abu Hena Chowdhury, Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh

    Associate Professor,Dermatology Department ,

    Bangabandhu Sheikh Mujib Medical University

    Shahbag, Dhaka, Bangladesh

  • Hasan Mahmud, Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh

    Registrar,Dermatology Department

    Kurmitola General Hospital,Dhaka

  • Rehnuma Nasim, Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka, Bangladesh

    Registrar,National Instituate of cancer research & hospital,

    Dhaka

References

1. Reinhold‐Keller E, Herlyn K, Wagner‐Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Care Res.2005;53(1):93-9.

2. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol.2008;9(2):71-92.

3. Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol.2005;27(6):504-28.

4. Pina T, Blanco R, González-Gay MA. Cutaneous vasculitis: a rheumatologist perspective. Curr Allergy Asthma Rep.2013;13(5):545-54.

5. Reinhold‐Keller E, Herlyn K, Wagner‐Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Care Res.2005;53(1):93-9.

6. van Zeben D, Bieger R, van Wermeskerken RK, Castel A, Hermans J. Evaluation of microcytosis using serum ferritin and red blood cell distribution width. Eur J Haematol.1990;44(2):106-9.

7. Danila MI, Bridges SL. Update on pathogenic mechanisms of systemic necrotizing vasculitis. Curr Rheumatol Rep.2008;10(6):430-5.

8. Seo P, Luqmani RA, Flossmann O, Hellmich B, Herlyn K, Hoffman GS, Jayne D, Kallenberg CG, Langford CA, Mahr A, Matteson EL. The future of damage assessment in vasculitis. J Rheumatol.2007;34(6):1357-71.

9. Kim HJ, Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Red blood cell distribution width can predict vasculitis activity and poor prognosis in granulomatosis with polyangiitis. Yonsei Med J.2018;59(2):294-302.

10. Weiss, G. and Goodnough, L.T. Anemia of chronic disease. N Engl J Med.2005;352(10):1011-23.

11. Öztürk ZA, Ünal A, Yiğiter R, Yesil Y, Kuyumcu ME, Neyal M, Kepekçi Y. Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)?. Arch Gerontol Geriatr.2013;56(1):50-4.

12. Grau GE, Roux-Lombard P, Gysler C, Lambert C, Lambert PH, Dayer JM, Guillevin L. Serum cytokine changes in systemic vasculitis. Immunology.1989;68(2):196.

13. Ozkalemkas F, Ali R, Ozkocaman V, Ozcelik T, Ozan U, Ozturk H, Kurt E, Evrensel T, Yerci O, Tunali A. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC cancer.2005;5(1):144.

14. Spell DW, Jones Jr DV, Harper WF, Bessman JD. The value of a complete blood count in predicting cancer of the colon. Cancer Detec Prev.2004;28(1):37-42.

15. Maruyama S, Hirayama C, Yamamoto S, Koda M, Udagawa A, Kadowaki Y, Inoue M, Sagayama A, Umeki K. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med.2001;138(5):332-7.

16. Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll of Cardiol. 2007;50(1):40-7.

17. Molnar T, Farkas K, Szepes Z, Nagy F, Nyari T, Wittmann T. RDW can be a useful additional marker in diagnosing Crohn's disease and ulcerative colitis. Dig Dis Sci.2008;53(10):2828.

18. Clarke K, Sagunarthy R, Kansal S. RDW as an additional marker in inflammatory bowel disease/undifferentiated colitis. Dig Dis Sci. 2008;53(9):2521-3.

19. Kiran, B.R., Naik, M.P. and Kumar, B.P. Clinico-Patho-Etiological Study of Cutaneous Vasculitis. IOSR J Dental Med Sci.2017;16(7):20-6

20. Asaduzzaman, A.T.M , Chowdhury, M.M.H., Jaigirdar, M.Q.H., Mahmud, M.M., Choudhury, A.M. and Paul, H.K. Clinicopathological study of cutaneous vasculitides. J Pak Assoc Dermatol.2016; 24(1):8-14

21. Watts RA, Scott DG. Epidemiology of the vasculitides. Curr Opin Rheumatol.2003; 15(1):11-6.

22. Mahr A, Guillevin L, Poissonnet M, Aymé S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg‐Strauss syndrome in a French urban multiethnic population in 2000: a capture–recapture estimate. Arthritis Care Res.2004;51(1):92-9.

23. Emiroglu N, Cengiz FP, Bahalı AG, Ozkaya DB, Su O, Onsun N. Red blood cell distribution width and neutrophil-to-lymphocyte ratio in patients with cutaneous vasculitis. Ann Clin Lab Sci.2017;47(2):162-5.

24. Kim DS, Shin D, Kim TG, Kim SH, Kim SM, Lee MG. Red blood cell distribution width as a useful indicator to predict systemic vasculitis in patients with cutaneous vasculitis. Rheumatol Int.2015;35(4):719-25.

25. Arhan M, ÖNAL İK, TAŞ A, KURT M, Kalkan IH, ÖZİN Y, Tunc B, ÜLKER A. The role of red cell distribution width as a marker in inflammatory bowel disease. Turkish J Med Sci.2011;41(2):227-34.

26. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med.2009;133(4):628-32.

Downloads

Published

10.04.2022

Issue

Section

Original Articles

How to Cite

1.
Determination of red blood cell distribution width in patients with primary cutaneous vasculitis compared to systemic vasculitis. J Pak Assoc Dermatol [Internet]. 2022 Apr. 10 [cited 2026 Sep. 11];31(3):334-41. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1619